XML 57 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
ORGANIZATION AND BASIS OF PRESENTATION - Reconciliation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
EPS of Common Stock      
Income from continuing operations $ 1,239 $ 1,003 $ 904
Less: Preferred dividends     (3)
Less: Undistributed earnings allocated to preferred shareholders     (1)
Income from continuing operations available to common stockholders 1,239 1,003 900
Discontinued operations, net of tax [1] 44 76 8
Less: Undistributed earnings allocated to preferred shareholders     0
Income from discontinued operations available to common stockholders 44 76 8
NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS 1,283 1,079 908
Income allocated to preferred shareholders, preferred dilutive     4
Income attributable to common stockholders, dilutive $ 1,283 $ 1,079 $ 912
Share Count information:      
Weighted average number of basic shares outstanding (in shares) 545,000 542,000 535,000
Assumed exercise of dilutive stock options and awards (in shares) 1,000 1,000 3,000
Assumed conversion of preferred stock (in shares)     4,000
Weighted average number of diluted shares outstanding (in shares) 546,000 543,000 542,000
Income attributable to common stockholders, per common share:      
Income from continuing operations, basic (in dollars per share) $ 2.27 $ 1.85 $ 1.69
Discontinued operations, basic (in dollars per share) 0.08 0.14 0.01
Basic - Net Income Attributable to Common Stockholders (in dollars per share) 2.35 1.99 1.70
Income from continuing operations, diluted (in dollars per share) 2.27 1.85 1.67
Discontinued operations, diluted (in dollars per share) 0.08 0.14 0.01
Diluted - Net Income Attributable to Common Stockholders (in dollars per share) $ 2.35 $ 1.99 $ 1.68
Antidilutive securities excluded from computation of EPS (in shares) 0 0 0
[1] Net of income tax benefit of $48 million, $59 million, and $5 million in 2021, 2020 and 2019, respectively.